NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s share price shot up 17.7% on Thursday . The stock traded as high as $4.00 and last traded at $4.12. 230,989 shares were traded during trading, a decline of 88% from the average session volume of 1,986,156 shares. The stock had previously closed at $3.50.
NovaBay Pharmaceuticals Trading Down 1.3%
The stock has a market cap of $435.49 million, a PE ratio of -0.35 and a beta of 0.57. The business has a fifty day simple moving average of $1.34 and a two-hundred day simple moving average of $1.21.
NovaBay Pharmaceuticals Dividend Announcement
The business also recently declared a dividend, which was paid on Monday, September 29th. Investors of record on Wednesday, October 1st were paid a $0.80 dividend. The ex-dividend date was Tuesday, September 30th. This represents a dividend yield of 3,791.0%.
Institutional Inflows and Outflows
About NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Featured Stories
- Five stocks we like better than NovaBay Pharmaceuticals
- Expert Stock Trading Psychology Tips
- Dollar General’s Turnaround Could Send the Stock Higher in 2026
- What Are Trending Stocks? Trending Stocks Explained
- Don’t Bet Against AppLovin: The Case Against the Shorts
- Where Do I Find 52-Week Highs and Lows?
- Micron’s Q1 Results Say “AI Bubble Is Far From Bursting”
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
